Clinical Data Disclosure Embraced By Pharma; Now It Needs Partners

Pfizer has not received many requests for its data and wants to find ways to encourage researchers to make the most use of available data; AstraZeneca’s Gregory Curt says the sharing of trial results eventually could eliminate the need for comparator arms.